Cargando…

Factors influencing response to Botulinum toxin type A in patients with idiopathic cervical dystonia: results from an international observational study

OBJECTIVES: Real-life data on response to Botulinum toxin A (BoNT-A) in cervical dystonia (CD) are sparse. An expert group of neurologists was convened with the overall aim of developing a definition of treatment response, which could be applied in a non-interventional study of BoNT-A-treated subjec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Misra, Vijay P, Ehler, Edvard, Zakine, Benjamin, Maisonobe, Pascal, Simonetta-Moreau, Marion
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Group 2012
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3378940/ https://www.ncbi.nlm.nih.gov/pubmed/22700836 http://dx.doi.org/10.1136/bmjopen-2012-000881

Ejemplares similares

Disease Progression of Idiopathic Cervical Dystonia in Spite of Improvement After Botulinum Toxin Therapy
por: Hefter, Harald, et al.
Publicado: (2020)

INTEREST IN CD2, a global patient-centred study of long-term cervical dystonia treatment with botulinum toxin
por: Misra, Vijay P., et al.
Publicado: (2017)

How satisfied are cervical dystonia patients after 3 years of botulinum toxin type A treatment? Results from a prospective, long-term observational study
por: Colosimo, Carlo, et al.
Publicado: (2019)

Correction to: How satisfied are cervical dystonia patients after 3 years of botulinum toxin type A treatment? Results from a prospective, long-term observational study
por: Colosimo, Carlo, et al.
Publicado: (2019)

Retroform Cervical Dystonia: Target Muscle Selection and Efficacy of Botulinum Toxin Injection
por: Hu, Yaowen, et al.
Publicado: (2022)

Chemodenervation for Oromandibular Dystonia Utilizing Botulinum Toxins
por: Ameer, Muhammad Atif, et al.
Publicado: (2021)

Botulinum toxin therapy of dystonia
por: Dressler, Dirk, et al.
Publicado: (2020)

White Matter Changes in Cervical Dystonia Relate to Clinical Effectiveness of Botulinum Toxin Treatment
por: Blood, Anne J., et al.
Publicado: (2019)

Relevance of sonography for botulinum toxin treatment of cervical dystonia: an expert statement
por: Schramm, Axel, et al.
Publicado: (2014)

Botulinum toxin therapy of cervical dystonia: comparing onabotulinumtoxinA (Botox(®)) and incobotulinumtoxinA (Xeomin(®))
por: Dressler, Dirk, et al.
Publicado: (2013)

Upper limb international spasticity study: rationale and protocol for a large, international, multicentre prospective cohort study investigating management and goal attainment following treatment with botulinum toxin A in real-life clinical practice
por: Turner-Stokes, Lynne, et al.
Publicado: (2013)

Impact of abobotulinumtoxinA on the clinical features of cervical dystonia in routine practice
por: Trosch, Richard M., et al.
Publicado: (2020)

Clinical Improvement After Treatment With IncobotulinumtoxinA (XEOMIN®) in Patients With Cervical Dystonia Resistant to Botulinum Toxin Preparations Containing Complexing Proteins
por: Hefter, Harald, et al.
Publicado: (2021)

Pain Relief in Cervical Dystonia with Botulinum Toxin Treatment
por: Camargo, Carlos Henrique Ferreira, et al.
Publicado: (2015)

Botulinum Toxin Therapy for Cervical Dystonia: The Science of Dosing
por: Evidente, Virgilio Gerald H., et al.
Publicado: (2014)

Spectrum of practice in the routine management of cervical dystonia with abobotulinumtoxinA: findings from three prospective open-label observational studies
por: Misra, Vijay P., et al.
Publicado: (2018)

Impact of integrated upper limb spasticity management including botulinum toxin A on patient-centred goal attainment: rationale and protocol for an international prospective, longitudinal cohort study (ULIS-III)
por: Turner-Stokes, Lynne, et al.
Publicado: (2016)

Botulinum toxin type A in the treatment of patients with cervical dystonia
por: Brashear, Allison
Publicado: (2009)

Effect of Botulinum Toxin on Non-Motor Symptoms in Cervical Dystonia
por: Costanzo, Matteo, et al.
Publicado: (2021)

The Role of Ultrasound for the Personalized Botulinum Toxin Treatment of Cervical Dystonia
por: Fietzek, Urban M., et al.
Publicado: (2021)

Dysphagia in cervical dystonia patients receiving optimised botulinum toxin therapy: a single-center retrospective cohort study
por: Kutschenko, Anna, et al.
Publicado: (2020)

Tremor in Idiopathic Cervical Dystonia – Possible Implications for Botulinum Toxin Treatment Considering the Col-Cap Classification
por: Pandey, Sanjay, et al.
Publicado: (2020)

Caregiver burden and health-related quality of life in idiopathic dystonia patients under botulinum toxin treatment: a cross-sectional study
por: Drexel, S. C., et al.
Publicado: (2019)

Consensus guidelines for botulinum toxin therapy: general algorithms and dosing tables for dystonia and spasticity
por: Dressler, Dirk, et al.
Publicado: (2021)

An open-label cohort study of the improvement of quality of life and pain in de novo cervical dystonia patients after injections with 500 U botulinum toxin A (Dysport)
por: Hefter, H, et al.
Publicado: (2013)

The Extreme Ends of the Treatment Response Spectrum to Botulinum Toxin in Cervical Dystonia
por: Samadzadeh, Sara, et al.
Publicado: (2020)

Improving the Efficacy of Botulinum Toxin for Cervical Dystonia: A Scoping Review
por: Erro, Roberto, et al.
Publicado: (2023)

Shear wave elastography combined with electromyography to assess the effect of botulinum toxin on spastic dystonia following stroke: A pilot study
por: Campanella, William, et al.
Publicado: (2022)

Very early reduction in efficacy of botulinum toxin therapy for cervical dystonia in patients with subsequent secondary treatment failure: a retrospective analysis
por: Hefter, Harald, et al.
Publicado: (2013)

Multimodal Quantitative MRI Reveals No Evidence for Tissue Pathology in Idiopathic Cervical Dystonia
por: Gracien, René-Maxime, et al.
Publicado: (2019)

Patient considerations in the treatment of cervical dystonia: focus on botulinum toxin type A
por: Mills, Reversa R, et al.
Publicado: (2015)

The Effect of Botulinum Toxin on Network Connectivity in Cervical Dystonia: Lessons from Magnetoencephalography
por: Mahajan, Abhimanyu, et al.
Publicado: (2017)

Treatment satisfaction with botulinum toxin: a comparison between blepharospasm and cervical dystonia
por: Leplow, Bernd, et al.
Publicado: (2017)

Spectral EMG Changes in Cervical Dystonia Patients and the Influence of Botulinum Toxin Treatment
por: Nijmeijer, S. W. R., et al.
Publicado: (2017)

Clinical Practice: Evidence-Based Recommendations for the Treatment of Cervical Dystonia with Botulinum Toxin
por: Contarino, Maria Fiorella, et al.
Publicado: (2017)

Botulinum toxin injection changes resting state cerebellar connectivity in cervical dystonia
por: Hok, Pavel, et al.
Publicado: (2021)

LIVECHART Patient‐Reported Outcome Tool for Botulinum Toxin Treatment in Cervical Dystonia
por: Chueluecha, Chuenchom, et al.
Publicado: (2022)

British Neurotoxin Network recommendations for managing cervical dystonia in patients with a poor response to botulinum toxin
por: Marion, Marie-Helene, et al.
Publicado: (2016)

Treatment of Blepharospasm and Oromandibular Dystonia with Botulinum Toxins
por: Hassell, Travis J.W., et al.
Publicado: (2020)

The Central Effects of Botulinum Toxin in Dystonia and Spasticity
por: Hok, Pavel, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qtldi6vt9ks1ak5elnqb4lh0o6